Long-term effectiveness of varicella vaccine: A 14-year, prospective cohort study

Pediatrics

Volumn 131, Issue 5, 2013, Pages

  Baxter, Roger ^a   Ray, Paula ^a   Tran, Trung N ^b   Black, Steve ^c   Shinefield, Henry R ^d   Coplan, Paul M ^e   Lewis, Edwin ^a   Fireman, Bruce ^a   Saddier, Patricia ^b  

^a KAISER PERMANENTE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e PURDUE PHARMA L P   (United States)

Author keywords

Chicken pox; Children; Effectiveness; Vaccine; Varicella; Zoster

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ARTICLE; CHICKENPOX; CHILD; COHORT ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; HERPES ZOSTER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; VACCINATION;

CHICKEN POX; CHILDREN; EFFECTIVENESS; VACCINE; VARICELLA; ZOSTER;

ADOLESCENT; AGE DISTRIBUTION; CALIFORNIA; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HERPES ZOSTER; HUMANS; INCIDENCE; INFANT; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; TIME FACTORS; VACCINATION;

EID: 84877041895     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-3303     Document Type: Article

References (40)

1. Takahashi M, Okuno Y, Otsuka T, Osame J, Takamizawa A. Development of a live attenuated varicella vaccine. Biken J. 1975;18(1):25-33
2. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1996;45(RR-11):1-36
3. Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J. 2002;21(10):931-935
4. Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis. 2000;182(2):383-390 (Pubitemid 30654820)
5. Finger R, Hughes JP, Meade BJ, Pelletier AR, Palmer CT. Age-specific incidence of chickenpox. Public Health Rep. 1994;109(6):750-755
6. Guess HA, Broughton DD, Melton LJ 3rd, Kurland LT. Population-based studies of varicella complications. Pediatrics. 1986;78 (4 pt 2):723-727 (Pubitemid 16007074)
7. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287(5):606-611 (Pubitemid 34252012)
8. Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis. 2008;197(suppl 2):S71-S75 (Pubitemid 351590150)
9. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med. 1984;310(22):1409- 1415 (Pubitemid 14101295)
10. Seward JF, Marin M, Vázquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis. 2008;197 (suppl 2):S82-S89 (Pubitemid 351590152)
11. Kuter B, Matthews H, Shinefield H, et al Study Group for Varivax. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23(2):132-137 (Pubitemid 38222785)
12. Lopez AS, Guris D, Zimmerman L, et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics. 2006;117(6). Available at: www.pediatrics.org/cgi/content/full/117/6/e1070
13. Chaves SS, Gargiullo P, Zhang JX, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007;356(11):1121-1129 (Pubitemid 46425596)
14. Lee BR, Feaver SL, Miller CA, Hedberg CW, Ehresmann KR. An elementary school outbreak of varicella attributed to vaccine failure: policy implications. J Infect Dis. 2004;190(3):477-483 (Pubitemid 38982083)
15. Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40
16. Kattan JA, Sosa LE, Bohnwagner HD, Hadler JL. Impact of 2-dose vaccination on varicella epidemiology: Connecticut-2005-2008. J Infect Dis. 2011;203(4):509-512
17. Shapiro ED, Vazquez M, Esposito D, et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203(3):312-315
18. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis. 2005;191(12):2002-2007 (Pubitemid 40800569)
19. Civen R, Chaves SS, Jumaan A, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009;28 (11):954-959
20. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20(19-20):2500-2507 (Pubitemid 34615588)
21. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002;360(9334):678-682 (Pubitemid 35232336)
22. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125(3):651-669 (Pubitemid 32156853)
23. Gidding HF, Brisson M, Macintyre CR, Burgess MA. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health. 2005;29(6):544-551 (Pubitemid 41782611)
24. Gordon NP. Similarity of the Adult Kaiser Permanente Membership in Northern California to the Insured and General Population in Northern California: Statistics from the 2007 California Health Interview Survey. Oakland, CA: Kaiser Permanente Division of Research; 2012
25. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a censusbased methodology. Am J Public Health. 1992;82(5):703-710
26. Selby JVSD, Johnson ES, Raebel MA, Friedman GD, McFarland BH, eds. Kaiser Permanente Medical Care Program. 4th ed. New York, NY: Wiley; 2005
27. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis. 1995;172(3):706-712
28. Yawn BP, Yawn RA, Lydick E. Community impact of childhood varicella infections. J Pediatr. 1997;130(5):759-765 (Pubitemid 27492614)
29. Coplan P, Black S, Rojas C, et al. Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease. Pediatr Infect Dis J. 2001;20(7):641-645 (Pubitemid 32652312)
30. Vessey SJ, Chan CY, Kuter BJ, et al. Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy. J Pediatr. 2001;139(2):297-304 (Pubitemid 32721721)
31. Nicolosi A, Sturkenboom M, Mannino S, Arpinelli F, Cantarutti L, Giaquinto C. The incidence of varicella: correction of a common error. Epidemiology. 2003;14(1):99-102 (Pubitemid 40416820)
32. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20
33. Black S, Shine field H, Ray P, et al. Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatr Infect Dis J. 1999;18(12):1041-1046
34. Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev. 2010;23(1):202-217
35. Giammanco G, Ciriminna S, Barberi I, Titone L, Lo Giudice M, Biasio LR. Universal varicella vaccination in the Sicilian paediatric population: rapid uptake of the vaccination programme and morbidity trends over fi ve years. Euro Surveill. 2009; 14(35)
36. Balfour HH Jr, Kelly JM, Suarez CS, et al. Acyclovir treatment of varicella in otherwise healthy children. J Pediatr. 1990;116 (4):633-639 (Pubitemid 20124165)
37. Chaves SS, Zhang J, Civen R, et al. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005. J Infect Dis. 2008;197(suppl 2):S127-S131 (Pubitemid 351590159)
38. Saddier P, Floret D, Guess HA, et al. Cost of varicella in France: a study in day care centers. J Infect Dis. 1998;178(suppl 1):S58-S63 (Pubitemid 28514272)
39. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61(5):310-316 (Pubitemid 12031812)
40. Russell ML, Schopflocher DP, Svenson L, Virani SN. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect. 2007;135(6):908-913 (Pubitemid 47616471)